48,830
edits
Difference between revisions of "Fecal calprotectin"
Jump to navigation
Jump to search
no edit summary
| Line 1: | Line 1: | ||
'''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal | last1 = Ayling | first1 = RM. | last2 = Kok | first2 = K. | title = Fecal Calprotectin. | journal = Adv Clin Chem | volume = 87 | issue = | pages = 161-190 | month = | year = 2018 | doi = 10.1016/bs.acc.2018.07.005 | PMID = 30342711 }}</ref> | '''Fecal calprotectin''' is a 36kDa protein and an inflammatory marker.<ref name=pmid30342711>{{Cite journal | last1 = Ayling | first1 = RM. | last2 = Kok | first2 = K. | title = Fecal Calprotectin. | journal = Adv Clin Chem | volume = 87 | issue = | pages = 161-190 | month = | year = 2018 | doi = 10.1016/bs.acc.2018.07.005 | PMID = 30342711 }}</ref> | ||
It is useful to differentiated IBD from irritable bowel syndrome,<ref>{{Cite journal | last1 = Nemakayala | first1 = DR. | last2 = Cash | first2 = BD. | title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? | journal = Curr Opin Gastroenterol | volume = 35 | issue = 1 | pages = 58-62 | month = Jan | year = 2019 | doi = 10.1097/MOG.0000000000000493 | PMID = 30407259 }} | It is useful to differentiated [[inflammatory bowel disease]] (IBD) from [[irritable bowel syndrome]],<ref name=pmid30407259>{{Cite journal | last1 = Nemakayala | first1 = DR. | last2 = Cash | first2 = BD. | title = Excluding irritable bowel syndrome in the inflammatory bowel disease patient: how far to go? | journal = Curr Opin Gastroenterol | volume = 35 | issue = 1 | pages = 58-62 | month = Jan | year = 2019 | doi = 10.1097/MOG.0000000000000493 | PMID = 30407259 }}</ref> and may be used to assess IBD activity. | ||
</ref> and may be used to assess IBD activity. | |||
==See also== | ==See also== | ||